
Organizations Select OnCore for Clinical Research Management
Six leading organizations selected the OnCore Enterprise Research system in 2013
Forte Research Systems, a leading developer of specialized clinical trial management systems (CTMS) and
The organizations chose OnCore to centrally manage clinical research operations, with half implementing the system across multidisciplinary research groups:
- University of Colorado Denver
- University of Hawaii Cancer Center
- Baylor College of Medicine
- Hoosier Oncology Group
- Fox Chase Cancer Center
- Northside Hospital
The addition of the new customers strengthens the position of the OnCore system as the trusted market leader, having long been established as the nation’s most widely adopted enterprise-class research management system among academic medical centers, cancer centers, and research hospitals.
Standards-based systems a growing trend
Tony O’Hare, Ph.D., Co-Founder and Chief Collaboration Officer at Forte, points to the company’s commitment to collaboration as a major contributor to the OnCore system’s success. “We listen to the needs of our customers and consistently deliver functionality that takes their operations to the next level,” he said.
In 2013, Forte released OnCore version 13.0, which was the largest release in the history of the system. It featured more than 150 enhancements, including redesigned
As a result of its successful product delivery, Forte has experienced substantial growth and in 2013 was ranked No. 2174 on Inc. magazine's sixth annual Inc. 500|5000, an exclusive ranking of the nation's fastest-growing private companies. It was the fourth consecutive year that Forte was ranked on the list.
About Forte Research Systems, Inc.
Founded in 2000 and headquartered in Madison, Wisconsin, Forte creates software and provides resources for better research compliance, patient safety, operational efficiency, and financial viability. Products include
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.